• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳-11标记的磷酸二酯酶5抑制剂的放射性合成作为用于阿尔茨海默病成像的新型潜在正电子发射断层显像(PET)放射性示踪剂

Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease.

作者信息

Dong Fugui, Du Jie, Miao Caihong, Jia Limeng, Li Wei, Wang Min, Zheng Qi-Huang, Xu Zhidong

机构信息

Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, College of Chemistry and Environmental Science, Hebei University, Baoding, Hebei, 071002, China.

Department of Radiology and Imaging Sciences, Indiana University School of Medicine, 1345 West 16th, Street, Room 202, Indianapolis, IN, 46202, USA.

出版信息

Appl Radiat Isot. 2019 Dec;154:108873. doi: 10.1016/j.apradiso.2019.108873. Epub 2019 Aug 22.

DOI:10.1016/j.apradiso.2019.108873
PMID:31470193
Abstract

To develop PET tracers for imaging of Alzheimer's disease, new carbon-11 labeled potent and selective PDE5 inhibitors have been synthesized. The reference standards (5) and (12), and their corresponding desmethylated precursors (6) and (13) were synthesized from methyl 2-amino-5-bromobenzoate and (4-methoxyphenyl)methanamine in multiple steps with 2%, 1%, 1% and 0.2% overall chemical yield, respectively. The radiotracers ([C]5) and ([C]12) were prepared from their corresponding precursors 6 and 13 with [C]CHOTf through O-C-methylation and isolated by HPLC combined with SPE in 40-50% radiochemical yield, based on [C]CO and decay corrected to EOB. The radiochemical purity was >99%, and the molar activity (A) at EOB was in a range of 370-740 GBq/μmol.

摘要

为了开发用于阿尔茨海默病成像的正电子发射断层显像(PET)示踪剂,已经合成了新型的碳-11标记的强效且选择性的磷酸二酯酶5(PDE5)抑制剂。参考标准品(5)和(12)以及它们相应的去甲基化前体(6)和(13)由2-氨基-5-溴苯甲酸甲酯和(4-甲氧基苯基)甲胺经多步合成,总化学产率分别为2%、1%、1%和0.2%。放射性示踪剂([C]5)和([C]12)由它们相应的前体6和13通过[C]CHOTf经O-C-甲基化制备,并通过高效液相色谱(HPLC)结合固相萃取(SPE)分离,基于[C]CO并校正至给药结束时(EOB)的放射性化学产率为40%-50%。放射性化学纯度>99%,给药结束时的摩尔活度(A)在370-740 GBq/μmol范围内。

相似文献

1
Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease.碳-11标记的磷酸二酯酶5抑制剂的放射性合成作为用于阿尔茨海默病成像的新型潜在正电子发射断层显像(PET)放射性示踪剂
Appl Radiat Isot. 2019 Dec;154:108873. doi: 10.1016/j.apradiso.2019.108873. Epub 2019 Aug 22.
2
Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [C]TPN171 as a new potential PET heart imaging agent.碳-11 标记 PDE5 抑制剂 [C]TPN171 的放射性合成作为一种新的潜在 PET 心脏成像剂。
Appl Radiat Isot. 2020 Aug;162:109190. doi: 10.1016/j.apradiso.2020.109190. Epub 2020 Apr 25.
3
Radiosynthesis of a carbon-11 labeled tetrahydrobenzisoxazole derivative as a new PET probe for γ-secretase imaging in Alzheimer's disease.一种用于阿尔茨海默病中γ-分泌酶成像的新型正电子发射断层显像(PET)探针——碳-11标记的四氢苯并异恶唑衍生物的放射性合成。
Appl Radiat Isot. 2020 Jan;155:108915. doi: 10.1016/j.apradiso.2019.108915. Epub 2019 Oct 1.
4
Radiosynthesis of a carbon-11-labeled AMPAR allosteric modulator as a new PET radioligand candidate for imaging of Alzheimer's disease.碳-11 标记的 AMPAR 变构调节剂的放射性合成作为一种新的 PET 放射性配体候选物,用于阿尔茨海默病的成像。
Bioorg Med Chem Lett. 2019 May 15;29(10):1177-1181. doi: 10.1016/j.bmcl.2019.03.027. Epub 2019 Mar 20.
5
Synthesis of carbon-11-labeled isonicotinamides as new potential PET agents for imaging of GSK-3 enzyme in Alzheimer's disease.碳-11标记异烟酰胺的合成作为用于阿尔茨海默病中GSK-3酶成像的新型潜在正电子发射断层显像剂。
Bioorg Med Chem Lett. 2017 Feb 15;27(4):740-743. doi: 10.1016/j.bmcl.2017.01.041. Epub 2017 Jan 16.
6
Synthesis of carbon-11-labeled CK1 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease.合成碳-11标记的细胞周期蛋白依赖性激酶1(CK1)抑制剂作为用于阿尔茨海默病成像的新型潜在正电子发射断层显像(PET)放射性示踪剂。
Bioorg Med Chem Lett. 2018 Jul 15;28(13):2234-2238. doi: 10.1016/j.bmcl.2018.05.053. Epub 2018 May 29.
7
Synthesis of carbon-11-labeled 5-HTR antagonists as new candidate PET radioligands for imaging of Alzheimer's disease.合成碳-11 标记的 5-HTR 拮抗剂作为阿尔茨海默病成像的新型 PET 放射性配体候选物。
Bioorg Med Chem Lett. 2018 Jun 1;28(10):1836-1841. doi: 10.1016/j.bmcl.2018.04.014. Epub 2018 Apr 7.
8
Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation.碳-11标记的可溶性环氧化物水解酶/磷酸二酯酶4双重抑制剂的简便合成作为用于神经炎症中可溶性环氧化物水解酶/磷酸二酯酶4酶成像的新型潜在正电子发射断层显像剂。
Bioorg Med Chem Lett. 2019 Jul 1;29(13):1654-1659. doi: 10.1016/j.bmcl.2019.04.036. Epub 2019 Apr 25.
9
Simple synthesis of new carbon-11-labeled 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives for PET imaging of A₃ adenosine receptor.用于A₃腺苷受体PET成像的新型碳-11标记的1,2,4-三唑并[4,3-a]喹喔啉-1-酮衍生物的简便合成
Appl Radiat Isot. 2014 Sep;91:71-8. doi: 10.1016/j.apradiso.2014.05.005. Epub 2014 May 21.
10
Synthesis of [(11)C]GSK1482160 as a new PET agent for targeting P2X(7) receptor.新型正电子发射断层显像(PET)靶向P2X(7)受体显像剂[(11)C]GSK1482160的合成
Bioorg Med Chem Lett. 2015 May 1;25(9):1965-70. doi: 10.1016/j.bmcl.2015.03.021. Epub 2015 Mar 14.

引用本文的文献

1
Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives.磷酸二酯酶5抑制剂的进展:揭示当前与未来展望
Pharmaceuticals (Basel). 2023 Sep 6;16(9):1266. doi: 10.3390/ph16091266.
2
A carbon-11 labeled imidazo[1,2-]pyridine derivative as a new potential PET probe targeting PI3K/mTOR in cancer.一种碳-11标记的咪唑并[1,2 -]吡啶衍生物,作为一种新型潜在的用于癌症中靶向PI3K/mTOR的正电子发射断层显像(PET)探针。
Am J Nucl Med Mol Imaging. 2023 Jun 25;13(3):95-106. eCollection 2023.
3
On the Viability of Tadalafil-Based F-Radiotracers for Phosphodiesterase 5 (PDE5) PET Imaging.
基于他达拉非的F放射性示踪剂用于磷酸二酯酶5(PDE5)正电子发射断层显像(PET)成像的可行性研究
ACS Omega. 2021 Aug 12;6(33):21741-21754. doi: 10.1021/acsomega.1c03315. eCollection 2021 Aug 24.
4
Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016.正电子发射断层扫描技术用于环核苷酸磷酸二酯酶成像的挑战:2016年以来的新型放射性配体及(临床前)研究洞察
Int J Mol Sci. 2021 Apr 7;22(8):3832. doi: 10.3390/ijms22083832.